Related Experiment Video
Updated: May 9, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Synthon-Based Strategies Exploiting Molecular Similarity and Protein-Ligand Interactions for Efficient Screening of
Brian Medel-Lacruz1,2, Albert Herrero2, Fernando Martín2
1Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain and Department of Medicine and Life Sciences, Pompeu Fabra University (UPF), 08003 Barcelona, Spain.
None:
The rapid expansion of ultralarge chemical libraries has revolutionized drug discovery, providing access to billions of compounds. However, this growth poses relevant challenges for traditional virtual screening (VS) methods. To address these limitations, synthon-based approaches have emerged as scalable alternatives, exploiting combinatorial chemistry principles to prioritize building blocks over enumerated molecules. In this work, we present exaScreen and exaDock, two novel synthon-based methodologies designed for ligand-based and structure-based VS, respectively. In the former case, synthon selection is guided by the 3D hydrophobic/philic distribution pattern in conjunction with a specific synthon alignment protocol based on a quadrupolar expansion over the atoms that participate in the linking bonds between fragments. On the other hand, accommodation to the binding site under a geometrically restrained docking of synthon-based hybrid compounds is used in the selection of the optimal synthon combinations. These strategies exhibit comparable performance to the search performed using fully enumerated libraries in identifying active compounds with significantly lower computational cost, offering computationally efficient strategies for VS in ultralarge chemical spaces.
Related Concept Videos
Drug Discovery: Overview
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-protein Interfaces

